Rituximab

Rituximab Therapeutic Cheat Sheet
RituximabRituximab was the first monoclonal antibody approved for cancer treatment and now in dermatology, this medication has been life-altering for patients with the severe, autoimmune blistering disease, pemphigus vulgaris. We continue our series, Therapeutic Cheat Sheet, with a closer look at rituximab, which is FDA-approved for the treatment of pemphigus vulgaris, and is also used off label for other …
Rituximab
JDD August 2023 Issue Highlights | Special Focus: Psoriasis
psoriasisWith a special focus on the topic of psoriasis, check out highlights from the August issue of the Journal of Drugs in Dermatology (JDD) straight from the JDD Editor’s desk: Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis delves into the expert guidance provided by the Psoriasis Expert Group (PEG), encompassing nine crucial statements that offer com …
psoriasis
Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the scalp, subtypes of alopecia areata include alopecia totalis with loss of all scalp hair and alopecia universalis with complete loss of all body hair. Although primarily an idiopathic condition, several …
It’s Mnemonic Monday! Stevens-Johnson Syndrome
SANAOn this Mnemonic Monday, we challenge you to remember major causes of drug-induced Stevens-Johnson Syndrome (SJS) with the following mnemonic: SANA Sulfonamides Anticonvulsants NSAIDs Allopurinol Click HERE to print your mnemonic card.   Study More! Need a refresher on Stevens-Johnson Syndrome? Check out the following pages of your 2019 Derm In-Review Study Guide: Stevens-Johnso …
SANA